Mondelēz Sells Developed-market Gum Business for $1.35 Billion

The transaction with Perfetti Van Melle will advance Mondelēz International’s strategy to increase its focus on a portfolio with chocolate, biscuits, and baked snacks as its core categories.

Perfetti Brands

Mondelēz International has sold its developed-market gum business in the U.S., Canada, and Europe to Perfetti Van Melle Group for $1.35 billion. Mondelēz will retain the Portugal portion of the business until regulatory approval is granted in that jurisdiction, after which it will be sold and transferred to Perfetti Van Melle Group.

The transaction includes Mondelēz manufacturing facilities in Rockford, Ill., and Skarbimierz, Poland, and the Trident, Dentyne, Stimorol, Hollywood, V6, Chiclets, Bubbaloo, and Bubblicious brands, as well as the European candy brands Cachou Lajaunie, Negro, and La Vosgienne. Mondelēz will continue to operate its gum business in Latin America, Asia, the Middle East, and Africa, and will retain ownership of all its other candy brands and products. The sale advances Mondelēz’ strategy to accelerate growth and enable a greater focus on growth and reinvestment in its core chocolate, biscuit, and baked snacks categories, and expands Perfetti Van Melle’s portfolio, which includes global brands such as Mentos, Chupa Chups, and Airheads.


   Mondelez International Opens $50M Global R&D Innovation Center


“As we continue accelerating growth to become the global snacking leader in chocolate, biscuits, and baked snacks, we are pleased to transition our developed market gum business to a global, privately owned, values-driven company with a strong and proven track record of brand investment and innovation,” says Dirk Van de Put, chairman and CEO, Mondelēz International.

“This acquisition aligns perfectly with our strategic goal of becoming a global leader in gum, our chosen focus,” says Egidio Perfetti, chairman of Perfetti Van Melle. “We expect to further bolster our product portfolio, manufacturing capacity, market distribution, and financial results, effectively doubling our size in North America and increasing our reach in Europe, serving more consumers with our well-loved brands.”


FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report